Nearly one in seven Britons who tested positive for COVID-19 continued to have symptoms for at least 12 weeks, according to a UK study released Thursday.
The Office for National Statistics said the study of over 20,000 people who had tested positive from April last year to March this year found 13.7 percent had symptoms that lasted for at least 12 weeks.
This was based on people’s self-reported symptoms of so-called “long COVID”. The list of 13 symptoms included fatigue, muscle pain and difficulty concentrating as well as loss of taste and smell.
Women were more more likely (14.7 percent) to report such long-lasting symptoms than men (12.7 percent).
Those aged 35-49 were most likely to report symptoms at five weeks (25.6 percent).
The study of UK patients was based on a random sample of 21,622 participants who tested positive from swabs and were asked about their symptoms monthly.
A control group who were unlikely to have been infected was also set up. It found they were eight times less likely to have such symptoms.
A larger survey of 1.1 million people self-reported long COVID over the four weeks ending March 6, 2021, the ONS said.
Ben Humberstone, Head of Health Analysis and Life Events at the ONS said this was its first analysis of new data and “our understanding of it and its quality will improve over time”.
Long COVID “is an emerging phenomenon that is not yet fully understood”, he added.
Britain, one of the countries worst hit by the pandemic, has recorded nearly 127,000 deaths from COVID and 4,350,266 cases.
However, the number of daily deaths and positive tests have fallen steadily amid a strong vaccination campaign.
Follow the latest news on the coronavirus (COVID-19) outbreak
© 2021 AFP
Almost one in seven suffers long COVID, UK study finds (2021, April 1)
retrieved 1 April 2021
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.
- COVID case rates hit new high for England, study finds - April 7, 2022
- Govt’s focus on affordable healthcare ensured significant savings for poor, middle class: PM Modi - April 7, 2022
- SRL Diagnostics and Skye Air Mobility collaborate to transport pathology samples using drone logistics - April 6, 2022
- Healthineers sets up new production line of CT scanners in Bengaluru under PLI scheme - April 6, 2022
- Lupin inks licensing pact with Alvion to market drugs in Southeast Asia - April 6, 2022
- Yoga Mahotsav: Ayush Ministry to organise event to demonstrate common yoga on World Health Day - April 6, 2022
- LordsMed forays into the medtech space with launch of health ATMs ‘Lords Sehat’ - April 5, 2022
- ‘Friendly viruses’ can be the next big thing in the history of medical research and more - April 5, 2022
- No setback to Bharat Biotech even as WHO suspends Covaxin UN supply: Sources - April 4, 2022
- Govt panel recommends Serum’s Covovax dose for kids aged 12 and above - April 4, 2022